ロード中...

Antiangiogenesis for Advanced Non-Small-Cell Lung Cancer in the Era of Immunotherapy and Personalized Medicine

Over the past decade, patients with advanced non-small-cell lung cancer (NSCLC) have witnessed substantial advances in regards to therapeutic alternatives. Among newly developed agents, angiogenesis inhibitors were extensively tested in different settings and have produced some favorable outcomes de...

詳細記述

保存先:
書誌詳細
出版年:Front Oncol
主要な著者: Tabchi, Samer, Blais, Normand
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2017
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC5372785/
https://ncbi.nlm.nih.gov/pubmed/28424759
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2017.00052
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!